文献速递重症综合管理与镇静镇痛

全球神经重症监护的组织:PRINCE研究第一部分结果

Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1.
PubMed 文献 · Neurocrit Care · 2020-01-01
一句话结论PRINCE研究显示全球神经重症监护在医院与ICU组织、资源配置和管理方案使用上存在显著差异,且国际协作收集全球实践数据可行。

PRINCE研究为多中心、国际性、点患病率、横断面、前瞻性、观察性、非干预性研究,分析初始阶段257个参与中心(来自47个国家)的注册、医院和ICU组织数据。多数ICU来自学术机构(73.4%),位于大城市中心(44%人口>100万)。医院和ICU组织、资源分配及患者管理方案使用存在显著差异。最高护患比为大洋洲(100% 1:1),专职高级实践提供者多见于北美(73.7%),专职呼吸治疗师在北美(85%)、中东(85%)和拉丁美洲(84%)常见,专职药师在北美(89%)和大洋洲(85%)最高,多数受访者拥有专职神经ICU(总体67%,北美最高82%,大洋洲最低14%)。结论提示神经重症监护实施存在显著变异性,国际协作收集全球数据可行。

要点

  • PRINCE研究纳入47个国家257个中心,多数为北美(46.3%)和学术机构(73.4%),医院与ICU组织及资源配置存在显著差异。
  • 专职神经ICU总体占67%,北美最高82%,大洋洲最低14%。
  • 护患比最高为大洋洲100% 1:1;专职高级实践提供者北美73.7%,大洋洲7.7%,中东0%。
  • 专职呼吸治疗师北美85%、中东85%、拉丁美洲84%常见,欧洲26%、大洋洲7.7%较少。
  • 专职药师北美89%、大洋洲85%最高,拉丁美洲38%最低。

适用人群与场景

  • 参与PRINCE研究的257个站点来自47个国家,包括北美119个(46.3%)、欧洲44个(17.2%)、亚洲34个(13.3%)、中东9个(3.5%)、拉丁美洲34个(13.3%)、大洋洲14个(5.5%)。
  • 多数ICU来自学术机构(73.4%),位于大城市中心(44%人口>100万)。

研究设计与关键结果

  • 研究设计为多中心、国际性、点患病率、横断面、前瞻性、观察性、非干预性研究,分析初始阶段注册、医院和ICU组织数据。
  • 共分析257个参与站点来自47个国家的信息,采用描述性统计,并用Kruskal-Wallis检验及Dunn程序检验世界区域间实践差异。
  • 医院和ICU组织、资源分配及患者管理方案使用存在显著差异。
  • 护患比最高为大洋洲(100% 1:1)。
  • 专职高级实践提供者多见于北美(73.7%),大洋洲(7.7%)和中东(0%)不常见。
  • 专职呼吸治疗师在北美(85%)、中东(85%)、拉丁美洲(84%)常见,欧洲(26%)和大洋洲(7.7%)较少。
  • 专职药师在北美(89%)和大洋洲(85%)最高,拉丁美洲(38%)最低。
  • 多数受访者拥有专职神经ICU(总体67%;北美最高82%;大洋洲最低14%)。

证据类型、等级与局限

  • 证据类型:多中心、国际性、点患病率、横断面、前瞻性、观察性、非干预性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • PRINCE研究结果提示神经重症监护的实施存在显著变异性。
  • 研究显示开展国际协作以收集全球神经重症监护实践数据是可行的。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Neurocritical care focuses on the care of critically ill patients with an acute neurologic disorder and has grown significantly in the past few years. However, there is a lack of data that describe the scope of practice of neurointensivists and epidemiological data on the types of patients and treatments used in neurocritical care units worldwide. To address these issues, we designed a multicenter, international, point-prevalence, cross-sectional, prospective, observational, non-interventional study in the setting of neurocritical care (PRINCE Study).

METHODS: In this manuscript, we analyzed data from the initial phase of the study that included registration, hospital, and intensive care unit (ICU) organizations. We present here descriptive statistics to summarize data from the registration case report form. We performed the Kruskal-Wallis test followed by the Dunn procedure to test for differences in practices among world regions.

RESULTS: We analyzed information submitted by 257 participating sites from 47 countries. The majority of those sites, 119 (46.3%), were in North America, 44 (17.2%) in Europe, 34 (13.3%) in Asia, 9 (3.5%) in the Middle East, 34 (13.3%) in Latin America, and 14 (5.5%) in Oceania. Most ICUs are from academic institutions (73.4%) located in large urban centers (44% > 1 million inhabitants). We found significant differences in hospital and ICU organization, resource allocation, and use of patient management protocols. The highest nursing/patient ratio was in Oceania (100% 1:1). Dedicated Advanced Practiced Providers are mostly present in North America (73.7%) and are uncommon in Oceania (7.7%) and the Middle East (0%). The presence of dedicated respiratory therapist is common in North America (85%), Middle East (85%), and Latin America (84%) but less common in Europe (26%) and Oceania (7.7%). The presence of dedicated pharmacist is highest in North America (89%) and Oceania (85%) and least common in Latin America (38%). The majority of respondents reported having a dedicated neuro-ICU (67% overall; highest in North America: 82%; and lowest in Oceania: 14%).

CONCLUSION: The PRINCE Study results suggest that there is significant variability in the delivery of neurocritical care. The study also shows it is feasible to undertake international collaborations to gather global data about the practice of neurocritical care.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Suarez JI, Martin RH, Bauza C, et al. Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1. Neurocrit Care. 2020. PMID: 31175567. doi:10.1007/s12028-019-00750-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。